NVAX MEXC RealStocks
Own real NVAX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 02:28:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Novavax Inc. (NVAX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $7.96, with a market capitalization of $1.33B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.20 to $13.39. This page covers its latest market performance, valuation, price trends and company information.
$1.33B | |
$7.90 | |
$8.31 | |
$7.86 | |
$7.96 | |
3.66M | |
6.83M | |
-- | |
$13.39 | |
$6.20 | |
-- | |
2026-09-30 |
Novavax Inc. (NVAX) last closed at $7.96 as of 2026-11-19 01:00:00, down 0.13% ($0.01) from the previous close of $7.96.
During the latest regular trading session, NVAX traded between $7.86 and $8.31, with a volume of 3.66M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Novavax Inc. (NVAX) moved from $10.89 to $7.96, representing a decline of 26.95% ($2.94).
The stock traded between $7.86 and $11.20 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 6.66 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 24.4%
NVAX is currently trading at $7.96, placing it 24.4% of the way from its 52-week low of $6.20 to its 52-week high of $13.39. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 749 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Novavax Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Dec 13, 2007 |
| Payment Date | Dec 31, 2007 |
| Dividend Per Share | $0.10625 |
Eligible investors can buy real shares of Novavax Inc. (NVAX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NVAX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between NVAX shares and USD.
NVAX Shares to USD
1.00 NVAX shares = 7.955 USD
Calculations are estimates based on the latest available price and are for reference only.